Skip to main content
    N

    NewGenIvf Group Limited Class A Ordinary Shares (NIVF)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.25
    -0.04 (-14.82%)

    Market Cap: $2.00M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Mar 26
    Reported Apr 1
    		$N/AN/AN/ABeat-
    Sep 25
    Reported Oct 9
    		$0.73$0.00N/ABeat+100.0%
    Mar 25
    Reported May 15
    		$0.00$0.00N/ABeat-100.0%
    Dec 24
    Reported Dec 31
    		$-2566.98N/AN/ABeat-130.1%
    Sep 24
    Reported Dec 5
    		$-0.04N/AN/ABeat-500.0%
    Dec 23
    Reported Dec 31
    		$-138459.21N/AN/ABeat-173074111.0%
    Sep 23
    Reported Sep 30
    		$12651.27N/AN/ABeat+63256236.0%
    Jun 23
    Reported Jun 30
    		$8515.48N/AN/ABeat+51987.9%
    Mar 23
    Reported Jun 29
    		$0.01N/AN/ABeat+150.0%
    Dec 22
    Reported Mar 30
    		$0.08N/AN/ABeat-
    Sep 22
    Reported Nov 9
    		$0.02N/AN/ABeat-
    Jun 22
    Reported Aug 12
    		$-16.41N/AN/ABeat-
    Mar 22
    Reported Jun 29
    		$-0.02N/AN/ABeat-
    Dec 21
    Reported Mar 30
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA0.38x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin24.20%Operating Margin-184.30%
    ROE5.51%ROIC29.95%
    Financial Health
    Debt/Equity0.16xInterest Coverage6.96x
    Current Ratio3.12xQuick Ratio2.98x
    Trading Statistics
    Beta0.06Avg Volume80.33M
    52-Week High$3348.0052-Week Low$0.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.34
    SMA 20$1.09
    SMA 50$3.77
    SMA 200$64.42
    EMA 10$0.48
    EMA 20$1.23
    EMA 50$5.59
    EMA 200$1700.23

    MACD

    Line: -1.20Signal: -1.37Hist: 0.17

    ADX

    ADX: 12.6+DI: 2.8-DI: 2.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down52.0
    PSAR$0.40

    Bollinger Bands

    Upper Band$3.26
    Lower Band$-1.07
    %B Position39627%(Upper)
    Band Width0.31

    RSI (14-Day)

    Oversold
    22.2

    Momentum Oscillators

    Stoch %K29.4
    Stoch %D23.9
    Williams %R-55.0
    ROC (10d)-38.1%
    Momentum-0.15
    CCI (20d)-47.4
    MFI (14d)91.0

    Volatility Measures

    ATR (14d)$1.69(674.9%)
    StdDev (20d)1.08
    Hist Vol662.3%(High)

    Volume Flow

    VWAP$0.25
    OBV1.5B
    AD Line35200.1B
    CMF (20d)12.050

    Volume Metrics

    Avg Vol (20d)88.4M
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.56

    Pivot Points

    R3$0.48
    R2$0.42
    R1$0.36
    Pivot Point$0.30
    S1$0.23
    S2$0.17
    S3$0.10

    Advanced Oscillators

    TSI-58.10
    Ultimate Osc74.7
    KST-890.19

    Financial Data

    QuarterDec 2025Sep 2025Mar 2025Dec 2024Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$1.42M$1.28M$1.27M$1.27M$1.47M$1.52MN/AN/AN/AN/AN/AN/A
    Cost of Revenue$900,529$1.16M$734,477$734,477$824,034$1.32MN/AN/AN/AN/AN/AN/A
    Gross Profit$524,025$118,017$539,135$539,135$648,827$196,825N/AN/AN/AN/AN/AN/A
    Operating Expenses$5.50M$2.63M$1.63M$2.36M$432,516$1.27M$1.27M$377,717$367,000$510,547$115,638$106,551
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$4.80M$2.44M$1.61M$1.63M$296,972$0$0$0$0$0$0$0
    Operating Income$-4,973,594$-2,512,491$-1,089,120$-1,089,120$216,311$196,825$-1,266,340$-377,717$-367,000$-510,547$-115,638$-106,551
    Interest Income$248$409$0$4,554$10,522$0$0$0$0$0$0$0
    Interest Expense$442,840$48,094$421,105$421,105$247,911$25,257$0$0$0$0$0$0
    Income Before Tax$-7,717,290$16.75M$-543,000$-542,684$-30,342$295,584$-955,489$127,021$85,497$52,120$474,362$208,323
    Income Tax Expense$0$0$-487,000$0$0$-83,742$0$0$0$0$0$0
    Net Income$-7,668,922$16.82M$-108,000$-108,243$-19,857$335,625$-955,489$127,021$85,497$52,120$474,362$208,323
    EBITDA$-7,274,450$16.80M$58,327$-121,579$226,870$363,775$-1,266,340$127,021$85,496$52,120$474,362$208,323
    EBIT$-7,274,450$16.80M$-121,577$-121,579$217,571$196,825$-1,266,340$-377,717$-367,000$-510,547$-115,638$-106,551
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NIVF

    News

    Form 4 NewGenIvf Group Ltd For: 11 October By Investing.com

    This article announces the filing of Form 4 by NewGenIvf Group Ltd for October 11th. Form 4 is a document that must be filed with the SEC whenever there is a material change in the holdings of company insiders....

    Investing.com India•10/11/26•Neutral

    Form 4 NewGenIvf Group Ltd For: 11 October By Investing.com

    This article announces the filing of a Form 4 for NewGenIvf Group Ltd on October 11. It's a brief financial markets news update provided by Investing.com...

    Investing.com Nigeria•10/11/26•Neutral

    Form 4 NewGenIvf Group Ltd For: 11 October By Investing.com

    This article reports on a Form 4 filing for NewGenIvf Group Ltd (NIVF) for the date of October 11. Form 4 filings disclose changes in beneficial ownership of a company's securities by insiders. The article includes...

    Investing.com Canada•10/11/26•Bearish

    NewGenIvf (NIVF) Stock Soars Over 28% After-Hours: What's Driving the Surge?

    NewGenIvf Group (NASDAQ: NIVF) shares surged 28.51% after hours to $0.13 following the announcement of the closure of a public offering that generated approximately $1.25 million in gross proceeds. The offering included...

    Benzinga•10/2/26•Bullish

    NewGen Announces Closing of $1.25 Million Public Offering

    NewGenIvf Group Limited (NASDAQ: NIVF) announced the closing of its public offering, raising approximately $1.25 million in gross proceeds. The offering included Class A Ordinary Shares and Pre-Funded Warrants....

    The Manila Times•9/30/26•Bullish

    NIVF Valuation and Fair Value

    Forward P/E
    0.0x
    EV/EBITDA
    0.4x
    P/B
    0.0x
    See GNG's fair value

    NIVF Profitability: Margins, ROIC and FCF

    Gross margin
    32.7%
    Operating margin
    -184.3%
    Net margin
    24.2%
    ROIC
    29.9%
    ROE
    5.5%
    FCF margin
    -130.3%

    NIVF Competitors

    CompanyTicker
    Beyond Air IncXAIR
    Purple BiotechPPBT
    BioRestorative Therapies IncBRTX
    Nexgel IncNXGL
    Clearside Biomedical IncCLSD
    Genprex IncGNPX
    Qualigen Therapeutics IncQLGN
    Oragenics IncOGEN

    Sector: Healthcare

    NIVF Bull Case vs Bear Case

    Bull case

    • NIVF earns a 29.9% return on invested capital.
    • NIVF has a 24.2% net profit margin.

    Bear case

    • NIVF's quarterly revenue changed -4.7% year over year.

    Frequently Asked Questions About NIVF

    Does NIVF pay dividends?

    NewGenIvf Group Limited Class A Ordinary Shares (NIVF) does not currently pay a regular dividend.

    What is NIVF's market cap?

    NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has a market capitalization of $2.00M with a current stock price of $0.25.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In